Zoladex
Menopausal Symptoms
Anglo Celtic Cooperative Oncology GroupPhase 3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 52/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Menopausal Symptoms cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Anglo Celtic Cooperative Oncology Group | Phase 3 | BB |
LENVATINIB Anglo Celtic Cooperative Oncology Group | Phase 3 | BB |
ESTROGENS, CONJUGATED Institute of Cancer Research, United Kingdom | Phase 3 | BB |
17-beta-estradiol Regional Oncologic Center | Phase 3 | BB |
Medroxyprogesterone acetate Eastern Cooperative Oncology Group | Phase 3 | BB |
View all 10 →
Same molecule, other indications
Zoladex is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →